MCCA
NVO

Mill Creek Capital Advisors’s Novo Nordisk NVO Stock Holding History

Mill Creek Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,797
Closed -$241K – 258
2024
Q4 		$241K Buy
2,797
+63
+2% +$6.81K 0.01% 240
2024
Q3 		$326K Sell
2,734
-390
-12% -$52K 0.01% 199
2024
Q2 		$446K Sell
3,124
-211
-6% -$28K 0.01% 172
2024
Q1 		$428K Sell
3,335
-829
-20% -$98.7K 0.01% 166
2023
Q4 		$431K Sell
4,164
-324
-7% -$32K 0.01% 163
2023
Q3 		$408K Buy
4,488
+324
+8% +$28.5K 0.01% 155
2023
Q2 		$337K Buy
4,164
+278
+7% +$22.7K 0.01% 174
2023
Q1 		$309K Hold
3,886
– – 0.01% 188
2022
Q4 		$263K Buy
+3,886
New +$228K 0.01% 192

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Mill Creek Capital Advisors's NVO Position: Q1 2025 in Review

Mill Creek Capital Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,797 shares — an estimated $241K sold.

Mill Creek Capital Advisors first reported a position in NVO in Q4 2022 and held it in 9 quarters. The position peaked at $446K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Mill Creek Capital Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Mill Creek Capital Advisors sold 2,797 Novo Nordisk shares in Q1 2025, an estimated $241K.
  • Mill Creek Capital Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 9 quarters.
  • Mill Creek Capital Advisors's Novo Nordisk position peaked at $446K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.